Trial Profile
Phase 2 Study of Pioglitazone in Follicular-patterned Thyroid Cancers That Contain the PAX8-PPARgamma Fusion Gene
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Pioglitazone (Primary)
- Indications Thyroid cancer
- Focus Therapeutic Use
- 10 May 2017 Status changed from recruiting to completed.
- 11 Aug 2012 New trial record